JPWO2021256427A1 - - Google Patents

Info

Publication number
JPWO2021256427A1
JPWO2021256427A1 JP2022505267A JP2022505267A JPWO2021256427A1 JP WO2021256427 A1 JPWO2021256427 A1 JP WO2021256427A1 JP 2022505267 A JP2022505267 A JP 2022505267A JP 2022505267 A JP2022505267 A JP 2022505267A JP WO2021256427 A1 JPWO2021256427 A1 JP WO2021256427A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022505267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021256427A1 publication Critical patent/JPWO2021256427A1/ja
Priority to JP2022141989A priority Critical patent/JP2022168328A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022505267A 2020-06-15 2021-06-14 Pending JPWO2021256427A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022141989A JP2022168328A (ja) 2020-06-15 2022-09-07 抗がん療法の増感剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020103121 2020-06-15
PCT/JP2021/022520 WO2021256427A1 (ja) 2020-06-15 2021-06-14 抗がん療法の増感剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022141989A Division JP2022168328A (ja) 2020-06-15 2022-09-07 抗がん療法の増感剤

Publications (1)

Publication Number Publication Date
JPWO2021256427A1 true JPWO2021256427A1 (ja) 2021-12-23

Family

ID=79268070

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022505267A Pending JPWO2021256427A1 (ja) 2020-06-15 2021-06-14
JP2022141989A Pending JP2022168328A (ja) 2020-06-15 2022-09-07 抗がん療法の増感剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022141989A Pending JP2022168328A (ja) 2020-06-15 2022-09-07 抗がん療法の増感剤

Country Status (11)

Country Link
US (1) US20230330230A1 (ja)
EP (1) EP4166147A1 (ja)
JP (2) JPWO2021256427A1 (ja)
CN (1) CN115803035A (ja)
AU (1) AU2021292668A1 (ja)
BR (1) BR112022025512A2 (ja)
CA (1) CA3182871A1 (ja)
IL (1) IL298758A (ja)
MX (1) MX2022015897A (ja)
WO (1) WO2021256427A1 (ja)
ZA (1) ZA202213321B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230256056A1 (en) * 2022-02-11 2023-08-17 Insitu Biologics, Inc. Sustained release cancer therapeutics formulations

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04506659A (ja) * 1989-05-09 1992-11-19 ピートロニグロ，デニス・ディ 抗腫瘍溶液
JP2006345701A (ja) * 2003-07-01 2006-12-28 Taisho Pharmaceut Co Ltd タキサン類応答性の判別方法
WO2008041514A1 (ja) * 2006-09-22 2008-04-10 Kochi University 放射線または抗がん化学療法増感剤
JP2012001566A (ja) * 1999-10-07 2012-01-05 Carlos Estuard Aguilar-Cordova 遺伝子治療による固体腫瘍及び転移の治療方法
WO2014126222A1 (ja) * 2013-02-15 2014-08-21 国立大学法人高知大学 ハイドロゲルを担体として過酸化水素を徐放する腫瘍内局注用の放射線/化学療法増感剤
JP2016014066A (ja) * 2002-07-18 2016-01-28 へリックス バイオファーマ コーポレイション 癌細胞増殖を阻害するためのウレアーゼの使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63123392A (ja) 1986-11-14 1988-05-27 Denki Kagaku Kogyo Kk ヒアルロン酸の製造方法
JP2587268B2 (ja) 1988-04-18 1997-03-05 チッソ株式会社 低粘度ヒアルロン酸又はその塩の製造方法
IT1219587B (it) 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
JPH02234689A (ja) 1989-03-09 1990-09-17 Denki Kagaku Kogyo Kk ヒアルロン酸の製造方法
CN1101405C (zh) 1997-08-22 2003-02-12 电气化学工业株式会社 透明质酸凝胶的制备方法、用此方法制得的透明质酸及包含这种凝胶的医用材料
KR100620291B1 (ko) 2000-02-03 2006-09-13 덴끼 가가꾸 고교 가부시키가이샤 히알루론산 겔, 이의 제조방법 및 이를 함유하는 의용재료
JP4958368B2 (ja) 2002-02-28 2012-06-20 電気化学工業株式会社 架橋ヒアルロン酸
TWI371447B (en) * 2005-04-01 2012-09-01 Taiho Pharmaceutical Co Ltd Radiotherapy enhancer having a pyridine derivative as an active ingredient

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04506659A (ja) * 1989-05-09 1992-11-19 ピートロニグロ，デニス・ディ 抗腫瘍溶液
JP2012001566A (ja) * 1999-10-07 2012-01-05 Carlos Estuard Aguilar-Cordova 遺伝子治療による固体腫瘍及び転移の治療方法
JP2016014066A (ja) * 2002-07-18 2016-01-28 へリックス バイオファーマ コーポレイション 癌細胞増殖を阻害するためのウレアーゼの使用
JP2006345701A (ja) * 2003-07-01 2006-12-28 Taisho Pharmaceut Co Ltd タキサン類応答性の判別方法
WO2008041514A1 (ja) * 2006-09-22 2008-04-10 Kochi University 放射線または抗がん化学療法増感剤
WO2014126222A1 (ja) * 2013-02-15 2014-08-21 国立大学法人高知大学 ハイドロゲルを担体として過酸化水素を徐放する腫瘍内局注用の放射線/化学療法増感剤

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CLINICALTRIALS.GOV ARCHIVE NCT03153085 ON 2020_03_05, ２０２０年３月５日, JPN6022022985, ISSN: 0004795131 *
日本医学放射線学会雑誌, vol. 44(7), JPN6022022986, 1984, pages 992 - 994, ISSN: 0004795129 *
日本臨床外科医学会雑誌, vol. 48(10), JPN6022022990, 1987, pages 1600 - 1610, ISSN: 0004795128 *
消化器癌, vol. 5(4), JPN6022022984, 1995, pages 309 - 313, ISSN: 0004795130 *

Also Published As

Publication number Publication date
WO2021256427A1 (ja) 2021-12-23
AU2021292668A1 (en) 2023-02-09
JP2022168328A (ja) 2022-11-07
CN115803035A (zh) 2023-03-14
EP4166147A1 (en) 2023-04-19
ZA202213321B (ja) 2024-04-24
CA3182871A1 (en) 2021-12-23
BR112022025512A2 (pt) 2023-01-17
MX2022015897A (es) 2023-01-24
US20230330230A1 (en) 2023-10-19
IL298758A (en) 2023-02-01

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
ZA202213321B (ja)
BR112022024743A2 (ja)
BR102021018859A2 (ja)
BR112022009896A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR112023009656A2 (ja)
BR112023006729A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016200A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220125

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220125

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20220214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220225

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220425

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220608

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220907

C116 Written invitation by the chief administrative judge to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C116

Effective date: 20220921

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220921

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20230222

C27C Written answer of applicant after an oral proceeding

Free format text: JAPANESE INTERMEDIATE CODE: C2721

Effective date: 20230222

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20230613

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231026